The Lipid-Lowering Agents market in Hungary is projected to witness a significant increase in revenue, reaching US$7.73m in 2024. This growth is expected to continue with an annual growth rate ...

The projected revenue for the Lipid-Lowering Agents market in Myanmar is expected to reach US$1.65m in 2024. With an annual growth rate (CAGR 2024-2029) of 0.00%, the market volume is estimated to ...

The availability of multiple lipid-lowering drugs and supplements provides new opportunities for patients to achieve target lipid levels. However, the variety of therapeutic options poses a ...

In this review we discuss evidence on the clinical benefit and safety of lipid-lowering agents for different stages of chronic kidney disease. Dyslipidemia is a well-established traditional risk ...

Other lipid-lowering agents have been shown to be more or less effective as well (Figure 1), especially when used in combination regimens. [2] Yet, a large percentage of treated patients still ...

The researchers said: 'We found that lipid-lowering drugs, particularly statins, were associated with decreased risk of 21 ...

MONCYTE Health, a diagnostics company based in Helsinki, has raised €1 million in a seed funding round to advance its ...

Are you searching for medications to treat 'Cholesterol'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Cholesterol. The page includes both ...

The Global Myocardial Infarction Therapeutics Market is estimated to be valued at USD 15.56 billion in 2023 and is projected to grow at a CAGR of 4.19% over the forecast period 2024-2032. Read the ...

DelveInsight’s, “Peripheral Arterial Disease Pipeline Insight 2024” report provides comprehensive insights about 18+ ...